Quest Diagnostics Incorporated logo
DGXQuest Diagnostics Incorporated

Average Return on Equity (ROE)

Return on Equity (ROE)

The latest reported return on equity (roe) is 13.84% as of Wednesday, December 31, 2025, shown against its trailing averages.

DGX Return on Equity (ROE)

DGX Average Return on Equity (ROE)

DGX Return on Equity (ROE) Averages

RETURN ON EQUITY (ROE) LATEST REPORTED

13.84%

RETURN ON EQUITY (ROE) TTM

13.34%

RETURN ON EQUITY (ROE) 3Y

14.07%

RETURN ON EQUITY (ROE) 5Y

18.07%

RETURN ON EQUITY (ROE) 10Y

16.59%

RETURN ON EQUITY (ROE) 15Y

14.40%

RETURN ON EQUITY (ROE) 20Y

15.69%

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Secaucus, NJ
55,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis